Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald Bunjes

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Transplantation and Cellular Therapy|March 20, 2024
Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported CauseElisa Sala, Adela M Neagoie, Jan Lewerenz, et al.
Vox Sanguinis|March 16, 2019
Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donorsDaniel Fürst, David Hauber, Peter Reinhardt, et al.
Radiology|December 21, 2006
Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial ExperienceAnja Dankerl, Peter Liebisch, Gerhard Glatting, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 28, 2002
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicitiesInga Buchmann, Donald Bunjes, Jörg Kotzerke, et al.
Frontiers in Immunology|May 31, 2023
Monitoring of strength, inflammation and muscle function in allogenic stem-cell transplantation patients - a pilot study for novel biomarker and risk stratification determinationSebastian Viktor Waldemar Schulz, Daniel Alexander Bizjak, Elena Moebes, et al.
Cancer Immunology, Immunotherapy : CII|September 30, 2006
Imatinib impairs CD8+ T lymphocytes specifically directed against the leukemia-associated antigen RHAMM/CD168 in vitroJinfei Chen, Anita Schmitt, Baoan Chen, et al.
British Journal of Haematology|January 16, 2007
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapseMark Ringhoffer, Stephanie von Harsdorf, Michael Schmitt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2017
Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Comparison of Eculizumab Therapy and Conventional TherapyStephan R Bohl, Florian Kuchenbauer, Stefanie von Harsdorf, et al.
Experimental Hematology|July 16, 2008
Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigensFei Fei, Yingzhe Yu, Anita Schmitt, et al.
Haematologica|January 7, 2017
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantationDaniel Fürst, Dietger Niederwieser, Donald Bunjes, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Transplantation and Cellular Therapy|March 20, 2024
Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported CauseElisa Sala, Adela M Neagoie, Jan Lewerenz, et al.
Vox Sanguinis|March 16, 2019
Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donorsDaniel Fürst, David Hauber, Peter Reinhardt, et al.
Radiology|December 21, 2006
Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial ExperienceAnja Dankerl, Peter Liebisch, Gerhard Glatting, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 28, 2002
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicitiesInga Buchmann, Donald Bunjes, Jörg Kotzerke, et al.
Frontiers in Immunology|May 31, 2023
Monitoring of strength, inflammation and muscle function in allogenic stem-cell transplantation patients - a pilot study for novel biomarker and risk stratification determinationSebastian Viktor Waldemar Schulz, Daniel Alexander Bizjak, Elena Moebes, et al.
Cancer Immunology, Immunotherapy : CII|September 30, 2006
Imatinib impairs CD8+ T lymphocytes specifically directed against the leukemia-associated antigen RHAMM/CD168 in vitroJinfei Chen, Anita Schmitt, Baoan Chen, et al.
British Journal of Haematology|January 16, 2007
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapseMark Ringhoffer, Stephanie von Harsdorf, Michael Schmitt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2017
Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Comparison of Eculizumab Therapy and Conventional TherapyStephan R Bohl, Florian Kuchenbauer, Stefanie von Harsdorf, et al.
Experimental Hematology|July 16, 2008
Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigensFei Fei, Yingzhe Yu, Anita Schmitt, et al.
Haematologica|January 7, 2017
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantationDaniel Fürst, Dietger Niederwieser, Donald Bunjes, et al.
Pageof 11